Page last updated: 2024-10-25

ciclopirox and Chronic Disease

ciclopirox has been researched along with Chronic Disease in 2 studies

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Daniel, CR1
Daniel, MP1
Daniel, J1
Sullivan, S1
Bell, FE1
Czaika, V1
Tietz, HJ1
Schmalreck, A1
Sterry, W1
Schultze, W1

Other Studies

2 other studies available for ciclopirox and Chronic Disease

ArticleYear
Managing simple chronic paronychia and onycholysis with ciclopirox 0.77% and an irritant-avoidance regimen.
    Cutis, 2004, Volume: 73, Issue:1

    Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chronic Dise

2004
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
    Mycoses, 2000, Volume: 43 Suppl 2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Flucon

2000